Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Department of Microbiology, Hyogo College of Medicine, Nishinomiya, 663-8501 Japan.
J Immunol. 2020 Mar 15;204(6):1621-1629. doi: 10.4049/jimmunol.1901234. Epub 2020 Jan 29.
Both immature and mature dendritic cells (DCs) can process and present foreign Ags to CD4 T cells; however, the mechanism by which MHC class II (MHC-II) in mature DCs acquires antigenic peptides remains unknown. To address this, we have studied Ag processing and presentation of two distinct CD4 T cell epitopes of the influenza virus hemagglutinin coat protein by both immature and mature mouse DCs. We find that immature DCs almost exclusively use newly synthesized MHC-II targeted to DM late endosomes for presentation to influenza virus-specific CD4 T cells. By contrast, mature DCs exclusively use recycling MHC-II that traffics to both early and late endosomes for antigenic peptide binding. Rab11a knockdown partially inhibits recycling of MHC-II in mature DCs and selectively inhibits presentation of an influenza virus hemagglutinin CD4 T cell epitope generated in early endosomes. These studies highlight a "division of labor" in MHC-II peptide binding, in which immature DCs preferentially present Ags acquired in Rab11a DM late endosomes, whereas mature DCs use recycling MHC-II to present antigenic peptides acquired in both Rab11a early endosomes and Rab11a endosomes for CD4 T cell activation.
未成熟和成熟树突状细胞 (DC) 均可处理和呈递外来抗原给 CD4 T 细胞;然而,成熟 DC 中 MHC Ⅱ类 (MHC-II) 获得抗原肽的机制尚不清楚。为了解决这个问题,我们研究了两种不同的流感病毒血凝素外壳蛋白的 CD4 T 细胞表位在未成熟和成熟的小鼠 DC 中的抗原加工和呈递。我们发现,未成熟的 DC 几乎只使用新合成的 MHC-II 靶向 DM 晚期内体来呈递流感病毒特异性 CD4 T 细胞。相比之下,成熟的 DC 只使用循环 MHC-II 来结合抗原肽,这些 MHC-II 可以运输到早期和晚期内体。Rab11a 的敲低部分抑制了成熟 DC 中 MHC-II 的循环利用,并选择性地抑制了在早期内体中产生的流感病毒血凝素 CD4 T 细胞表位的呈递。这些研究强调了 MHC-II 肽结合的“分工”,其中未成熟的 DC 优先呈递在 Rab11a DM 晚期内体中获得的抗原,而成熟的 DC 则使用循环利用的 MHC-II 来呈递在 Rab11a 早期内体和 Rab11a 内体中获得的抗原肽,以激活 CD4 T 细胞。